Tower Research Capital (TRC)’s Cartica Acquisition Corp Class A Ordinary Shares CITE Stock Holding History

Tower Research Capital (TRC)’s Portfolio CITE Stock Details CITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-120	Closed	-$1.42K	–	6034
2024 Q4	$1.42K	Buy	120 +5	+4%	+$58	﹤0.01%	5021
2024 Q3	$1.32K	Hold	115	–	–	﹤0.01%	5174
2024 Q2	$1.3K	Buy	115 +106	+1,178%	+$1.19K	﹤0.01%	5175
2024 Q1	$100	Sell	9 -663	-99%	-$7.31K	﹤0.01%	5656
2023 Q4	$7.33K	Buy	672 +183	+37%	+$1.98K	﹤0.01%	4626
2023 Q3	$5.27K	Buy	489 +244	+100%	+$2.61K	﹤0.01%	4742
2023 Q2	$2.61K	Buy	245 +236	+2,622%	+$2.5K	﹤0.01%	5178
2023 Q1	$0	Buy	+9	New	+$94	﹤0.01%	6408

Other funds holding CITE

MSU

Mizuho Securities USA New York $4.24B AUM 22.54% 1-Year Est. Return

Tower Research Capital (TRC)'s CITE Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Cartica Acquisition Corp Class A Ordinary Shares (CITE) in Q1 2025, closing a stake of 120 shares — an estimated $1.42K sold.

Tower Research Capital (TRC) first reported a position in CITE in Q1 2023 and held it in 8 quarters. The position peaked at $7.33K in Q4 2023. 1 fund tracked by Wall St. Rank holds CITE as of Q1 2025.

Tower Research Capital (TRC) reported no remaining Cartica Acquisition Corp Class A Ordinary Shares position as of Q1 2025 after selling out during the quarter.
Tower Research Capital (TRC) sold 120 Cartica Acquisition Corp Class A Ordinary Shares shares in Q1 2025, an estimated $1.42K.
Tower Research Capital (TRC) first reported a position in Cartica Acquisition Corp Class A Ordinary Shares in Q1 2023 and held it in 8 quarters.
Tower Research Capital (TRC)'s Cartica Acquisition Corp Class A Ordinary Shares position peaked at $7.33K in Q4 2023.
1 fund tracked by Wall St. Rank held Cartica Acquisition Corp Class A Ordinary Shares as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.